Galapagos N.V. | Key People and Executives
Onno van de Stolpe
Chief Executive Officer & Executive Director
Christine Mummery
Independent Non-Executive Director
Harrold van Barlingen
Independent Non-Executive Director
Mary Kerr
Independent Non-Executive Director
Katrine S. Bosley
Independent Non-Executive Director
Howard Rowe
Independent Non-Executive Director
Werner Cautreels
Independent Non-Executive Director
Onno van de Stolpe
Chief Executive Officer & Executive Director
Bart Filius
Chief Financial Officer
Walid Abi-Saab
Chief Medical Officer
Piet Wigerinck
Chief Scientific Officer
Paul van der Horst
Director-Business Development
Andre Hoekema
Senior Vice President-Corporate Development
Elizabeth Goodwin
VP-Corporate Communications & Investor Relations
Evelyn Fox
Director-Communications & Head-Media Relations
Xavier Marie Bernard Cecile Maes
Secretary
Christine Mummery
Independent Non-Executive Director
Harrold van Barlingen
Independent Non-Executive Director
Mary Kerr
Independent Non-Executive Director
Katrine S. Bosley
Independent Non-Executive Director
Howard Mitchell Rowe
Independent Non-Executive Director
Werner Cautreels
Independent Non-Executive Director
| Address |
Industriepark Mechelen Noord
Mechelen BU 2800
Belgium
|
|
Employees
|
- |
| Website |
http://www.glpg.com |
| Updated |
07/08/2019 |
| Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium. |
